Publications by authors named "E Bashan"
Article Synopsis
- A community-based endocrinology center integrated d-Nav technology for autonomous insulin titration to improve diabetes care, addressing the challenges of frequent insulin adjustments and persistent hyperglycemia in long-term type 2 diabetes patients.* -
- After using d-Nav for an average of 8.2 months, the first 600 patients saw significant reductions in glycated hemoglobin (HbA1c), dropping from an initial average of 8.6% to 7.3%, with fewer patients experiencing high HbA1c levels.* -
- The approach led to a reduction in total daily insulin doses for some patients, a low incidence of hypoglycemia, and encouraged the appropriate use of additional diabetes medications, demonstrating
Background: For patients using basal-bolus insulin therapy, it is widespread clinical practice to aim for a 50-50 ratio between basal and total daily bolus. However, this practice was based on a small study of individuals without diabetes. To assess the rule in real-world practice, we retrospectively analyzed patients on basal-bolus therapy that was adjusted at least weekly by an artificial intelligence-driven titration within the d-Nav® Insulin Management Technology.
View Article and Find Full Text PDFIn patients with type 2 diabetes, insulin therapy necessitates regular and frequent dosage titration to overcome variations in insulin requirements. The goal of this study was to evaluate changes in insulin requirements, using data from a technology-based insulin-titration service. To keep glycemia stable, the service adjusts and records insulin dosage at least weekly.
View Article and Find Full Text PDF